Arlington, TN, USA—The Dynasty® Dual Mobility Acetabular Liners and the E-Class® Vitamin E Blended Dual Mobility Inserts, both independently developed and designed by MicroPort® Orthopedics received 510(k) approval from the US Food and Drug Administration (FDA) for marketing in the United States.
The Dynasty® Dual Mobility Acetabular Cup System is an artificial joint prosthesis designed and developed to mimic the physiological structure of the human hip joint. It consists of a metal shell and a highly cross-linked polyethylene liner, effectively reducing the rate of dislocation during hip replacement procedures. The Vitamin E blended polyethylene material can prevent the acetabular liner from oxidation and enhance its wear resistance, which is especially recommended for elderly people who need to undergo repair surgeries for hip fractures or hip revisions, as well as for patients with neuromuscular diseases with a high risk of dislocation. It helps increase the stability and mobility of the hip joint after surgery and offers the possibility of achieving a “zero” acetabulum dislocation rate in clinical practices.
About MicroPort® Orthopedics
MicroPort Orthopedics leverages extensive experience in orthopedics and excellent clinical results to improve patient outcomes and drive provider satisfaction across the globe. The mission of MicroPort Orthopedics is to become the trusted partner of healthcare professionals who share a belief that hip and knee replacements of the past are not good enough for the patient today. In partnership with surgeons, MicroPort helps patients get back on their feet quickly. With a focus on innovation combined with demonstrated capability to deliver the resources of an industry leader, MicroPort Orthopedics is helping patients worldwide achieve full function faster each and every day. To learn more, visit www.microportortho.com.